Back to search
FDAFDA · Food and drugs·Recall number Z-2089-2025

ADVIA® 120/2120/2120i 3-in-1 TESTpoint Control (ABN2 Control)

Published July 9, 2025 · Recall initiated: June 4, 2025

Summary

FDA records medical device Class II recall Z-2089-2025, published July 9, 2025 and initiated June 4, 2025. Recalling firm: Siemens Healthcare Diagnostics, Inc.; Status: Ongoing; Reported quantity: 3,266 units; Lot: Siemens Material Number 10318905; UDI: 00630414473413, 00630414473413; Lot No. TP253035, TP253045. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Products have the incorrect platelet (PLT) value assignments for the ADVIA 120/2120/2120i Hematology Systems.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Siemens Healthcare Diagnostics, Inc.
Distributor
Worldwide distribution - US Nationwide and the countries of AR, AU, BR, CA, CL, CN, CO, CR, HK, ID, IN, JP, KR, MX, MY, PE, PY, SA, SG, TH, TW, UY, VN, & ZA.
Lot
Siemens Material Number 10318905; UDI: 00630414473413, 00630414473413; Lot No. TP253035, TP253045.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was ADVIA® 120/2120/2120i 3-in-1 TESTpoint Control (ABN2 Control) recalled?

Yes. FDA published recall Z-2089-2025 on July 9, 2025. Reported hazard: Products have the incorrect platelet (PLT) value assignments for the ADVIA 120/2120/2120i Hematology Systems.

What should I do if I have this product?

Voluntary: Firm initiated · Letter